Keyphrases
Hysterectomy
88%
Myomectomy
62%
Ureter
50%
Laparoscopic Hysterectomy
50%
Fibroids
42%
Minimally Invasive
40%
Dual-wavelength
38%
Photoacoustic Imaging
33%
Uterine Artery
32%
Minimally Invasive Myomectomy
32%
Photoacoustic
28%
Oral Morphine Equivalent
26%
Postoperative Narcotic Use
25%
Postoperative Outcomes
25%
Risk Factors
25%
Randomized Controlled Trial
25%
Parking Sensors
25%
Symptomatic Uterine Fibroids
25%
Robotically Assisted
25%
Minimally Invasive Gynecologic Surgery
25%
Open Radical Hysterectomy
25%
Cadaver
25%
Genitourinary Syndrome of Menopause
25%
Ceftriaxone
25%
Uterosacral Ligament
25%
Minimally Invasive Approach
25%
Laparoscopic-assisted
25%
Surgical Management
25%
Cell Salvage
25%
Reduced Susceptibility
25%
Feasibility Outcomes
25%
High-order
25%
Bupivacaine
25%
Improved Patient Outcomes
25%
Intraoperative Cell Salvage
25%
Enterobacteriaceae Bacteraemia
25%
Robotic Hysterectomy
25%
Opioid Use
21%
Oxycodone
20%
Surgical Tools
17%
Estimated Blood Loss
15%
Opioid Usage
15%
Laparoscopy
15%
Laparoscopic Myomectomy
12%
Clinical Standards
12%
Uterine Fibroids
12%
Female Reproductive Tract
12%
Fluid Management
12%
Anti-adhesion Barrier
12%
Ultrasound-guided Radiofrequency Ablation
12%
Medicine and Dentistry
Hysterectomy
100%
Uterine Myomectomy
75%
Ureter
75%
Cadaver
53%
Gynecological Surgery
43%
Ureter Injury
42%
Photoacoustic Imaging
33%
Surgeon
33%
Uterine Artery
32%
Surgery
27%
Bleeding
25%
In Vitro Fertilisation
25%
Ceftriaxone
25%
Reproductive Endocrinology
25%
Laparoscopy
25%
Glycon
25%
Enterobacteriaceae
25%
Bacteremia
25%
Health Care Cost
25%
Transgender
25%
Injury
18%
Laparotomy
18%
Female Reproductive Tract
12%
Minimally Invasive Procedure
12%
Surgical History
12%
Patient Care
12%
Uterine Fibroid
12%
Umbilicus
12%
Ultrasound-Guided Radiofrequency Ablation
12%
Benign Tumor
12%
Quality of Life
12%
Surgical Approach
12%
Preoperative Treatment
12%
Anatomy
12%
Symptom
12%
Recurrent Disease
12%
Uterus Bleeding
12%
Patient Selection
12%
Combination Therapy
12%
Cystoscopy
10%
Lactam
9%
Odds Ratio
7%
Operation Duration
7%
Retrospective Cohort Study
7%
Blood Transfusion
7%
Carbene
7%
Ospemifene
7%
Distance Measurement
6%
Polycystic Ovary Syndrome
6%
Informed Consent
5%